Skip to main content
. 2019 May 8;10(2):316–325. doi: 10.1055/s-0039-1688553

Table 1. Features included in the AdaBoost v1 and v2 models.

Model Initial model Revised model (additional features)
Admission details Admission diagnosis
Date/Time
Admitting physician
Admitting ward
Admitting division
HCDP code
Primary care provider (PCP)
PCP location
Sociodemographics Year of birth
Ethnicity/Race
Sex/Gender
Marital status
Military grade
Insurance coverage
Home Zip code
Military rank
Comorbidities Acute coronary syndrome
Alcohol abuse
Anemia
Arrhythmia
Asthma
Atherosclerosis
Cancer
Cardiorespiratory failure
CHF
CKD
Cerebrovascular disease
Complicated diabetes
Connective tissue disorder
COPD
Dementia
Depression
Fluid disorders
Gastrointestinal disorder
Other liver disease
HIV
Lung disorder
Malnutrition
Myocardial Infarction
Nephritis
Other heart disease
Paralysis
Peptic ulcer
PVD
Other psychiatric disorder
Renal failure
Rheumatic
Sepsis
Solid tumor
Ulcer
Uncomplicated diabetes
Urinary tract disorder
Pneumonia
Charlson Comorbidity Index
Vital signs Heart rate
Respiratory rate
Temperature
Systolic blood pressure
Diastolic blood pressure
Pain score
Pharmacy Number of prescriptions
Number of new prescriptions
Rx filled (total)
Rx dispensed (index admission)
Rx dispensed (prior to admission)
Medication type (NDC class)
Laboratory results Sodium, glucose, calcium, potassium, creatinine, blood urea nitrogen, total protein, albumin, total cholesterol, white blood cell count, red blood cell count, hemoglobin, hematocrit, platelets, international normalized ratio (INR), alanine transaminase (ALT), aspartate transaminase (AST), bilirubin, brain natriuretic peptide (BNP), pro-BNP

Abbreviations: CHF, congestive heart failure; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; HCDP, health care delivery program; HIV, human immunodeficiency virus; PCP, primary care provider; NDC, National Drug Class; PVD, peripheral vascular disease; Rx, prescriptions.